Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

MCKESSON CORPORATION

(MCK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

U.S. Drug distributors propose $10 billion to end state lawsuits over opioids: Bloomberg

share with twitter share with LinkedIn share with facebook
08/06/2019 | 12:02pm EDT
FILE PHOTO: Pharmaceutical tablets and capsules are arranged on a table in this picture illustration

(Reuters) - Drug wholesalers AmerisourceBergen Co, McKesson Corp and Cardinal Health Inc have proposed a $10 billion settlement for claims that they played a part in the U.S. opioid epidemic, Bloomberg reported on Tuesday, citing people familiar with negotiations.

Hundreds of lawsuits by states and cities have been filed nationally accusing drugmakers of deceptively marketing opioids and distributors such as AmerisourceBergen Corp, Cardinal Health Inc and McKesson Corp of ignoring suspicious orders.

Shares of AmerisourceBergen, McKesson and Cardinal Health were down about 5%.

The National Association of Attorneys General, negotiating on behalf of more than 35 states, countered with a demand for $45 billion to cover costs, according to the Bloomberg report.

"We regularly engage with the state attorneys general, but the company has made no settlement offers," McKesson said in a statement.

Cardinal Health and AmerisourceBergen did not immediately respond to Reuters' request for comment.

(Reporting by Ankur Banerjee in Bengaluru; Editing by Shinjini Ganguli)

Stocks mentioned in the article
ChangeLast1st jan.
AMERISOURCEBERGEN CORPORATION -0.79% 102.73 Delayed Quote.20.83%
CARDINAL HEALTH, INC. -2.58% 52.43 Delayed Quote.3.66%
LINE CORPORATION -0.18% 5410 End-of-day quote.1.12%
MCKESSON CORPORATION -0.53% 152.19 Delayed Quote.10.03%
WALGREENS BOOTS ALLIANCE, INC. -1.96% 41 Delayed Quote.-30.46%
share with twitter share with LinkedIn share with facebook
All news about MCKESSON CORPORATION
08/11MCKESSON : The Awakening of a Road Warrior
PU
08/04MCKESSON : The US Oncology Network Names Vivek Kavadi, MD, Chief Radiation Oncol..
PU
08/03MCKESSON : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
08/03Nasdaq hits record high close as traders eye M&A and stimulus
RE
08/03Microsoft, Apple lift Wall St as investors await stimulus
RE
08/03Earnings, Microsoft boost Wall St as investors await stimulus
RE
08/03Microsoft, Apple lift Wall Street as investors await stimulus
RE
08/03Earnings, Microsoft set to boost Wall St as investors await stimulus
RE
08/03MCKESSON : Lifts FY21 Adjusted Profit Forecast As Volumes Look Better
DJ
08/03MCKESSON : 1Q Sales, Adjusted Profit Ahead Of Expectations, But Pandemic Weighs ..
DJ
More news
Financials (USD)
Sales 2021 239 B - -
Net income 2021 2 181 M - -
Net Debt 2021 1 547 M - -
P/E ratio 2021 11,3x
Yield 2021 1,13%
Capitalization 24 684 M 24 684 M -
EV / Sales 2021 0,11x
EV / Sales 2022 0,10x
Nbr of Employees 70 000
Free-Float 59,6%
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 182,87 $
Last Close Price 152,19 $
Spread / Highest target 38,0%
Spread / Average Target 20,2%
Spread / Lowest Target -1,44%
EPS Revisions
Managers
NameTitle
Brian Scott Tyler Chief Executive Officer & Director
Edward A. Mueller Chairman
Britt Vitalone Chief Financial Officer & Executive Vice President
Nancy Flores EVP, Chief Technology & Information Officer
M. Christine Jacobs Independent Director
Sector and Competitors